Hide metadata

dc.contributor.authorGutema, Girma
dc.contributor.authorEngidawork, Ephrem
dc.date.accessioned2019-01-01T10:02:36Z
dc.date.available2019-01-01T10:02:36Z
dc.date.issued2018
dc.identifier.citationBMC Research Notes. 2018 Dec 27;11(1):925
dc.identifier.urihttp://hdl.handle.net/10852/66006
dc.description.abstractObjective In national drug policies of many countries, ensuring availability and affordability of essential medicines is indicated among the major policy objectives. To achieve the objectives, countries with low and middle income compile such medicines into NEMLs. This study aims to determine availability and affordability of commonly prescribed antibiotics at a tertiary hospital in Ethiopia by assessing (in private and public pharmacies) 13 antibiotics constituting DU90% at the hospital. Results Availability of the antibiotics in the private and public pharmacies was 92.3% and 98.5%, respectively. Average MPRs for the antibiotics were 4.1 and 2.7, respectively, in the private and public pharmacies. The days’ wages (in median prices) ranged from 0.2 for treating acute diarrhea with doxycycline to 415.8 for treating HAP in public pharmacies. Costs of a single day treatment with antibiotics purchased from the public pharmacies ranged from USD 0.1 for acute diarrhea to USD 29.7 for HAP. For the private pharmacies, the range was from USD 0.1 for toxoplasmosis to USD 54.9 for HAP. This study showed that treatments of commonly diagnosed infectious conditions at TASH remain unaffordable according to the WHO/HAI criteria.
dc.language.isoeng
dc.rightsThe Author(s)
dc.rightsAttribution 4.0 International
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.titleAffordability of commonly prescribed antibiotics in a large tertiary teaching hospital in Ethiopia: a challenge for the national drug policy objective
dc.typeJournal article
dc.date.updated2019-01-01T10:02:37Z
dc.creator.authorGutema, Girma
dc.creator.authorEngidawork, Ephrem
dc.identifier.doihttps://doi.org/10.1186/s13104-018-4021-2
dc.identifier.urnURN:NBN:no-68512
dc.type.documentTidsskriftartikkel
dc.type.peerreviewedPeer reviewed
dc.identifier.fulltextFulltext https://www.duo.uio.no/bitstream/handle/10852/66006/1/13104_2018_Article_4021.pdf
dc.type.versionPublishedVersion
cristin.articleid925


Files in this item

Appears in the following Collection

Hide metadata

Attribution 4.0 International
This item's license is: Attribution 4.0 International